US · Healthcare

Full Alliance Group Inc (FAGI)

Drug Manufacturers - Specialty & Generic

Full Alliance Group Inc (FAGI) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for FAGI

P/E ratio

18.00

Full Alliance Group Inc (FAGI) — FAQ

What is FAGI's P/E ratio?

The price-to-earnings (P/E) ratio for Full Alliance Group Inc (FAGI) is 18.00 (data as of 2026-03-24).

Does Full Alliance Group Inc pay a dividend?

Dividend yield is not available in the current snapshot for Full Alliance Group Inc (FAGI). Check the MyAverix Finance app for the latest dividend data.

What sector is Full Alliance Group Inc in?

Full Alliance Group Inc (FAGI) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is FAGI listed on?

FAGI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)